维克塔46中间导管用于远端中血管封闭的机械血栓切除:一个单中心体验
Joo Won Choi1, Yang Qiao2,3, Tej I Mehta4
1Department of Neurosciences, UC San Diego School of Medicine, La Jolla, CA, USA.
概括
AXS Vecta 46导管有效地治疗远端中血管封闭 (DMVO),具有高的回通道率. 这种机械血栓切除方法对中风患者显示出有希望的结果,在临床结果中证明了安全性和有效性.
科学领域:
- 神经学 神经学
- 干预性神经辐射学
- 血管外科 血管外科
背景情况:
- 机械血栓切除术 (MT) 越来越多地用于远端中血管封闭 (DMVOs).
- 需要专门的设备来导航扭曲的远端大脑血管系统.
- AXS Vecta 46中间导管是为这些具有挑战性的解剖学而设计的.
研究的目的:
- 评估AXS Vecta 46导管的安全性和有效性,用于DMVOs的一线血栓吸收.
- 评估使用该设备的DMVO接受MT的患者的再通道化率和临床结果.
主要方法:
- 一个单中心的回顾性研究,对使用Vecta 46对DMVOs进行MT的患者进行.
- 收集的数据包括基线特征,手术细节,血管检查结果 (脑梗塞中修改型血栓溶解得分≥2b) 和临床结果.
- 分析重新通道率,第一通道效应 (FPE) 和程序并发症.
主要成果:
- 治疗了54名DMVOs (M2,M3,M4,A2-A4,P1-P4) 的43名患者.
- 主要DMVO的成功重定向率为100%,次要DMVO的成功率为80.6%.
- 在55.6%的病例中观察到第一通效应 (FPE),改善了短期临床结果 (NIHSS转移在两组均为-5).
结论:
- AXS Vecta 46中间导管在初级和二级DMVOs中对血栓吸收安全有效.
- 该设备实现了高率的成功重新通道化和第一通道效应.
- 这种方法显示了DMVOs中风患者改善临床结果的潜力.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
3
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
3